RecruitingNot ApplicableNCT07165860

Clinical Trial to Reduce Perinatal Intimate Partner Violence

Novel Doula Intervention to Leverage Clinic-community Connections to Support Perinatal Intimate Partner Violence Survivors


Sponsor

University of Pittsburgh

Enrollment

326 participants

Start Date

Nov 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria8

  • \) feel comfortable completing the study in Spanish or English
  • \) are age 18 or older
  • \) are no more than 22 weeks gestation
  • \) identify as an IPV survivor by answering affirmatively to a definition of experiencing IPV
  • \) live within a 50 mile radius of Pittsburgh, Pennsylvania
  • \) able to provide safe and complete contact information or take a study cell phone
  • Cannot provide safe contact information or take a study cell phone
  • Incarcerated

Exclusion Criteria1

  • Unable to consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDoulas

The intervention will be pairing intimate partner violence survivors with a trained doula

BEHAVIORALThrive

The active control arm will include pairing intimate partner violence survivors with IPV advocates


Locations(3)

Magee Women's Hospital

Pittsburgh, Pennsylvania, United States

The Midwife Center

Pittsburgh, Pennsylvania, United States

Family Medicine Department

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07165860


Related Trials